Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29809738 | 1.00 | ALDH1A1 (0.56) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL8763318 | 0.92 | ALDH1A1 (0.50) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL1716296 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL9914900 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL956458 | 0.87 | ALDH1A1 (0.52) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL24176025 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL860437 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL3917506 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL3812333 | 0.87 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL31686029 | 0.87 | ALDH1A1 (0.52) | ALDH1A1HPGDCYP1A1CYP1A2CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113330609-B | Conductive agent, method for producing same, electrochemical device, and electronic device | 宁德新能源科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-113330609-A | Conductive agent, method for producing same, electrochemical device, and electronic device | 宁德新能源科技有限公司 | 2021-08-31 | — | — | CN | claimed |
| EP-3238707-B1 | COMPOSITIONS AND METHODS FOR TREATING INTESTINAL HYPERPERMEABILITY | HOFFMAN STEVE (US) | 2021-02-17 | — | — | EP | claimed |
| US-20150133628-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2015-05-14 | — | — | US | claimed |
| US-20130123542-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2013-05-16 | — | — | US | claimed |
| EP-2522688-A1 | POLYAMINE AND METHOD FOR PRODUCING THE SAME | Rhodia Operations (FR) | 2012-11-14 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
| US-4201868-A | Reaction of methanol with synthesis gas | CELANESE CORPORATION (US) | 1980-05-06 | — | — | US | claimed |
| US-4138429-A | Process for the manufacture of o-phenylenediacetonitrile | CIBA-GEIGY CORPORATION (US) | 1979-02-06 | — | — | US | claimed |
| US-4048212-A | Process for the manufacture of 1,4-dicyanonaphthalenes | CIBA-GEIGY CORPORATION (US) | 1977-09-13 | — | — | US | claimed |
| US-4025543-A | Process for the preparation of 1,4-naphthodinitrile | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-05-24 | — | — | US | claimed |
| US-4011261-A | PROCESS FOR THE MANUFACTURE OF 1,4-DISUBSTITUTED BICYCLIC OR TRICYCLIC COMPOUNDS AND NEW 1,4-DISUBSTITUTED BICYCLIC COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1977-03-08 | — | — | US | claimed |
| US-20240307409-A1 | ARGININE METHYLTRANSFERASE INHIBITOR AND USE THEREOF | CYTOSINLAB THERAPEUTICS CO., LTD. (CN) | 2024-09-19 | — | — | US | disclosed |
| US-4011261-A | PROCESS FOR THE MANUFACTURE OF 1,4-DISUBSTITUTED BICYCLIC OR TRICYCLIC COMPOUNDS AND NEW 1,4-DISUBSTITUTED BICYCLIC COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1977-03-08 | — | — | US | disclosed |
| US-3917665-A | Preparation of phenylene diacetonitrile | EXXON RESEARCH ENGINEERING CO | 1975-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240307409-A1 | ARGININE METHYLTRANSFERASE INHIBITOR AND USE THEREOF | PRMT1, PRMT7, PRMT8 | ALDH1A1 2456/4885HPGD 2408/4885CYP1A1 1843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.